GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Millennium Pharmacon International Tbk (ISX:SDPC) » Definitions » Other Net Income (Loss)

PT Millennium Pharmacon International Tbk (ISX:SDPC) Other Net Income (Loss) : Rp0 Mil (TTM As of Dec. 2024)


View and export this data going back to 1990. Start your Free Trial

What is PT Millennium Pharmacon International Tbk Other Net Income (Loss)?

PT Millennium Pharmacon International Tbk's Other Net Income (Loss) for the three months ended in Dec. 2024 was Rp0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was Rp0 Mil.

PT Millennium Pharmacon International Tbk's quarterly Other Net Income (Loss) declined from Jun. 2024 (Rp0 Mil) to Sep. 2024 (Rp0 Mil) but then stayed the same from Sep. 2024 (Rp0 Mil) to Dec. 2024 (Rp0 Mil).

PT Millennium Pharmacon International Tbk's annual Other Net Income (Loss) declined from Dec. 2022 (Rp0 Mil) to Dec. 2023 (Rp-6 Mil) but then increased from Dec. 2023 (Rp-6 Mil) to Dec. 2024 (Rp-0 Mil).


PT Millennium Pharmacon International Tbk Other Net Income (Loss) Historical Data

The historical data trend for PT Millennium Pharmacon International Tbk's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Millennium Pharmacon International Tbk Other Net Income (Loss) Chart

PT Millennium Pharmacon International Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -6.33 -

PT Millennium Pharmacon International Tbk Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PT Millennium Pharmacon International Tbk Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Millennium Pharmacon International Tbk Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of PT Millennium Pharmacon International Tbk's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Millennium Pharmacon International Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan.Sultan Iskandar Muda No 18, Crown Bungur Arteri Lantai 2-4th Floors, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The operating segments of the group are Prescription medicine, Non-prescription medicine, and Medical devices, of which the majority of the revenue is derived from the Prescription Medicine segment.. The company's geographical segments are Java, Sumatera, Kalimantan, Sulawesi, and Bali.

PT Millennium Pharmacon International Tbk Headlines

No Headlines